1. A note from the publisher

   Announcement Pages: i - i

2. Small cell anaplastic carcinoma of the lung

   • Brian A. Brigham

   Review Pages: 1 - 5

3. Haematopoietic late effects of prolonged bleomycin treatment in mice

   • M. R. Nowrousian
   • C. G. Schmidt

   Original Articles Pages: 6 - 9

4. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts

   • D. R. Gandara
   • C. A. Ries
   • S. K. Carter

   Original Articles Pages: 10 - 12

5. Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease

   • N. Thatcher
   • H. Sharma
   • B. W. Fox

   Original Articles Pages: 13 - 16

6. Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate

   • Paul A. Volberding
   • Michael A. Friedman
   • Theodore L. Phillips

   Original Articles Pages: 17 - 21

7. Bleomycin clinical pharmacology by radioimmunoassay

   • Stephen W. Hall
   • James E. Strong
   • Robert S. Benjamin

   Original Articles Pages: 22 - 25

8. Biliary elimination of cyclophosphamide in man

   • J. S. Dooley
   • C. A. James
   • R. Stuart-Harris

   Original Articles Pages: 26 - 29

9. The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia

   • Adrian L. Harris
   • David G. Grahame-Smith

   Original Articles Pages: 30 - 35

10. Effects of cis-diamminedichloroplatinum (CDDP) on HeLa cell non-histone nuclear proteins

    • Michael Nazimiec
    • Stanley T. Crooke
    • Archie W. Prestayko

    Original Articles Pages: 36 - 40

11. Vindesine: Phase II evaluation in colon cancer and description of its platelet stimulating activity

    • Richard Pazdur
    • Arthur H. Rossof
    • Janet Wolter

    Original Articles Pages: 41 - 44

12. Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells

    • Danielle Londos-Gagliardi
    • Roger Baurain
    • Geneviève Aubel-Sadron

    Original Articles Pages: 45 - 48

13. Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes

    • L. W. Brox
    • E. Pollock
    • A. Belch

    Original Articles Pages: 49 - 52

14. Phase I and II study of AMSA in childhood tumours

    • Ann Goldman
    • J. S. Malpas

    Original Articles Pages: 53 - 56

15. Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma

    • I. A.-K. Taha
    • R. A. Ahmad
    • H. J. Rogers

    Original Articles Pages: 57 - 60

16. Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

    • Rudolf A. Joss
    • Renato L. Galeazzi
    • Kurt W. Brunner

    Original Articles Pages: 61 - 64

17. Pharmacokinetics of erythrocyte methotrexate after high-dose methotrexate

    • Andreas Schalhorn
    • Hansjörg Sauer
    • Gabriele Stupp-Poutot

    Original Articles Pages: 65 - 69